Investors & Media

Whats new.

Press releases

Press releases.

Immutep to Present TACTI-002 Interim Data at German Cancer Congress

February 4th 2020
press releases

Immutep Activities Report

January 29th 2020
press releases

Immutep Expands Part C of TACTI-002 due to Positive Data

January 8th 2020
press releases

Investor updates

Investor updates.

Investor Update - November 2019

November 22nd 2019
investor updates

Investor Update - January 2019

January 31st 2019
investor updates

Investor Update - June 2018

June 19th 2018
investor updates

Analyst reports

Analyst reports.

Bell Potter - Global leader in LAG-3, the hottest emerging immune checkpoint (Analyst: Tanushree Jain tnjain@bellpotter.com.au)

February 18th 2020
analyst reports

Maxim - Inflection Points Approaching- Lung Cancer Data (February), Breast Cancer Data (March)

January 30th 2020
analyst reports

Maxim - TACTI-002 Head & Neck Cancer Study is Expanding, Data Updates Over 2020 – Reiterate Buy

January 10th 2020
analyst reports